Our findings suggest that IL-1α rs1800587 in the TT genotype of the donor may contribute to a reduced rate of acute GVHD, which could be helpful in selecting potential donors and for specified GVHD prophylaxis. This evidence concerns the gene IL1A and graft versus host disease.